We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitamin and Asthma Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01447173
First Posted: October 6, 2011
Last Update Posted: October 23, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Yanbin Dong, Georgia Health Sciences University
October 3, 2011
October 6, 2011
October 23, 2012
December 2010
September 2011   (Final data collection date for primary outcome measure)
  • Change in Pulmonary Function Test (PFT) after vitamin D supplementation [ Time Frame: 4 weeks ]
  • Change in Asthma Control Test (ACT) scores after vitamin D supplementation [ Time Frame: 4-week ]
  • Change in PFT after vitamin D supplementation [ Time Frame: 4 weeks ]
  • Change in Asthma Control Test (ACT) scores after vitamin D supplementation [ Time Frame: 4-week ]
Complete list of historical versions of study NCT01447173 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vitamin and Asthma Study
Not Provided
The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Asthma
Drug: Vitamin D
Vitamin D 2000 IU daily pill Vitamin D 400 IU daily pill
  • Experimental: 2000 IU vitamin D Daily
    Intervention: Drug: Vitamin D
  • Placebo Comparator: 400 IU Vitamin D pill
    Intervention: Drug: Vitamin D
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
September 2011
September 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • History of asthma (under control)otherwise in good general health

Exclusion Criteria:

  • Poorly controlled asthma
  • Taking daily multivitamin or vitamin D supplementation
  • Taking oral steroid medication
  • History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders
Sexes Eligible for Study: All
7 Years to 17 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01447173
VDAS
Not Provided
Not Provided
Not Provided
Yanbin Dong, Georgia Health Sciences University
Augusta University
Not Provided
Not Provided
Augusta University
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP